Kindstar to Offer Insight Genetics' ALK Lung Cancer Screening Test | GenomeWeb

NEW YORK (GenomeWeb News) – Insight Genetics and Kindstar Globalgene Technology announced Thursday evening a licensing deal for the Insight ALK Screen lung cancer test.

Under the terms, Insight ALK Screen will be added to Kindstar's menu of tests directed at cancer diagnosis and care offered in China and surrounding areas. Kindstar anticipates offering Insight ALK Screen in China, Hong Kong, and Macau starting next month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.